Sage Therapeutics Inc (SAGE)
11.88
+0.10
(+0.85%)
USD |
NASDAQ |
May 28, 15:01
Sage Therapeutics Gross Profit (TTM): 87.86M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 87.86M |
| December 31, 2023 | 84.30M |
| September 30, 2023 | 9.866M |
| June 30, 2023 | 9.61M |
| March 31, 2023 | 8.642M |
| December 31, 2022 | 6.874M |
| September 30, 2022 | 5.707M |
| June 30, 2022 | 5.461M |
| March 31, 2022 | 5.655M |
| December 31, 2021 | 5.755M |
| September 30, 2021 | 1.113B |
| Date | Value |
|---|---|
| June 30, 2021 | 1.113B |
| March 31, 2021 | 1.113B |
| December 31, 2020 | 1.114B |
| September 30, 2020 | 6.326M |
| June 30, 2020 | 8.269M |
| March 31, 2020 | 8.119M |
| December 31, 2019 | 6.468M |
| September 30, 2019 | 5.00M |
| June 30, 2019 | 1.567M |
| March 31, 2019 | 90.74M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
1.567M
Minimum
Jun 2019
1.114B
Maximum
Dec 2020
235.94M
Average
8.194M
Median
Gross Profit (TTM) Benchmarks
| Biogen Inc | 7.250B |
| Vanda Pharmaceuticals Inc | 164.14M |
| Ligand Pharmaceuticals Inc | 108.64M |
| ADMA Biologics Inc | 111.54M |
| Axsome Therapeutics Inc | 226.22M |